Reinsurance Group of America, Incorporated · RZC · FY2025 Q1 · Calendar Q2 2025
RGA posts strong Q1 as transactions and Asia drive growth
The supplied analysis supports a constructive but execution-dependent view: strong profitability, favorable claims experience, capital capacity, and Creation Re expansion support continued growth, while transaction integration, claims volatility, macro uncertainty, and variable investment income remain important counterweights.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about RZC FY2025 Q1
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The current analysis emphasizes strong Q1 profitability, favorable biometric claims, $418 million of capital deployment, and $1.9 billion of excess capital. Relative to the prior analysis, the focus shifts toward executing the Equitable transaction, expanding Creation Re and Asia activity, and managing variable investment income and transaction-related uncertainty.
Guidance delta
No new guidance was provided in the supplied analysis.
Key takeaways
- Management reported adjusted operating earnings of $5.66 per share and 15% ROE.
- Favorable biometric claims experience contributed $196 million of economic benefit and $58 million of financial benefit.
- Management highlighted $418 million of capital deployment, $1.9 billion of excess capital, and Creation Re as growth drivers.
Management priorities
- Expand Creation Re partnerships and bespoke products.
- Complete and integrate the Equitable transaction while pursuing additional block transactions in Asia.
- Continue capital optimization and explore third-party capital and hybrid debt financing.
Follow RZC with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeCompany context
Snapshot as of publicationReinsurance Group of America, Inc. functions as a holding company, concentrating on both conventional and cutting-edge life and health reinsurance offerings. Its operations are structured across five primary segments: the U.S. and Latin America, Canada, Europe, the Middle East and Africa (EMEA), Asia Pacific, and a distinct Corporate and Other division. The U.S. and Latin America segment is responsible for marketing individual and group life and health reinsurance to clients within its region, employing various agreement types such as yearly renewable term, coinsurance, and modified coinsurance.…
Historical context
All RZC earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| FDS FactSet Research Systems Inc. | FY2026 Q4 · Calendar Q3 2026 | +3.9% | +3.8% | FactSet reports record FY26 results as AI and MCP adoption accelerate |
| PUK Prudential plc | FY2026 Q2 · Calendar Q3 2026 | -40.9% | -0.5% | Prudential sustains growth and capital returns focus in H1 2026 |
| CM Canadian Imperial Bank of Commerce | FY2026 Q3 · Calendar Q3 2026 | +8.9% | -2.8% | CIBC Q3: Broad growth, resilient credit and expanded AI rollout |
| TD The Toronto-Dominion Bank | FY2026 Q3 · Calendar Q3 2026 | +13.8% | +1.4% | TD emphasizes growth investments alongside disciplined capital management |
| RY Royal Bank of Canada | FY2026 Q3 · Calendar Q3 2026 | +6.2% | -1.3% | RBC reports record Q3 earnings while investing for growth |
| AFRM Affirm Holdings, Inc. | FY2026 Q4 · Calendar Q3 2026 | +1230.3% | +0.3% | Affirm's most profitable quarter shifts focus to product execution |
Latest beats and misses
Who reports nextBeat on EPS
- RPMFY2027 Q1 · October 6, 2026+1.5% EPS+3.2% move
- ACNFY2026 Q4 · October 1, 2026+3.5% EPS+15.8% move
- MKCFY2026 Q3 · October 1, 2026+13.9% EPS-4.9% move
- NKEFY2027 Q1 · October 1, 2026+10.0% EPS-0.7% move
- CAGFY2027 Q1 · September 30, 2026+44.4% EPS-4.9% move
- FDSFY2026 Q4 · September 30, 2026+3.9% EPS+3.8% move
Get the RZC recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-10-07T02:30:44.430923+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-07. For educational purposes only; not investment advice.